Radiation Oncology Program
The UCSF Radiation Oncology Program is among the nation's best for patients who require radiation therapy. We match you with a team of experts on your particular cancer and the best techniques for treating it. Along with UCSF's advanced technologies and our safe care practices, this expertise enables us to provide patients with the best possible outcomes.
We specialize in using high-dose, precisely targeted X-rays to shrink or eliminate tumor cells with minimal damage to surrounding healthy tissues. Depending on the patient, the goal is to destroy cancer, keep it from spreading, or improve quality of life by relieving pain and other symptoms.
Alongside our commitment to outstanding patient care, our team is dedicated to finding safer and more effective cancer therapies through research. Interested patients may have the opportunity to receive promising experimental treatments by joining a clinical trial.
For information on what to expect during your first appointment, how to prepare for your visits and more, please see our FAQ.
Learn more about clinical trials and how they work.
Doctor referral required
Our locations (5)
Our team
-
Mekhail Anwar
MD, PhD
Radiation oncologist -
Steve Braunstein
MD, PhD
Radiation oncologist -
Jason Chan
MD
Radiation oncologist -
Felix Feng
MD
Radiation oncologist -
Mary Feng
MD
Radiation oncologist -
Julie Frank
LCSW, MSW
Social worker -
Christine Glastonbury
MBBS
Neuroradiologist -
Julian Hong
MD, MS
Radiation oncologist -
I-Chow (Joe) Hsu
MD, FACR, FASTRO
Radiation oncologist -
Amelia Komp
NP, MSN
Nurse practitioner -
Natalie Olsen
NP, MSN
Nurse practitioner -
Catherine C. Park
MD
Radiation oncologist -
Teddy Scheel
LCSW, MPH
Social worker -
Steven Seyedin
MD
Radiation oncologist -
Lisa Singer
MD, PhD
Radiation oncologist -
Matt Susko
MD, MS
Radiation oncologist -
Harish N. Vasudevan
MD, PhD
Radiation oncologist -
Anthony C. Wong
MD, PhD
Radiation oncologist -
Sue Yom
MD, PhD
Radiation oncologist -
Emi Yoshida
MD
Radiation oncologist -
Florence Yuen
NP, MSN
Nurse practitioner
-
Jesse Alexander
MD, PhD
Radiation oncologist -
Jason Chan
MD
Radiation oncologist -
Julie Frank
LCSW, MSW
Social worker -
Alexander R. Gottschalk
MD, PhD
Radiation oncologist -
I-Chow (Joe) Hsu
MD, FACR, FASTRO
Radiation oncologist -
Amelia Komp
NP, MSN
Nurse practitioner -
Kavita K. Mishra
MD, MPH
Radiation oncologist -
Nicolas Prionas
MD, PhD
Radiation oncologist -
Mack Roach III
MD
Radiation oncologist -
Teddy Scheel
LCSW, MPH
Social worker -
Lisa Singer
MD, PhD
Radiation oncologist -
Matt Susko
MD, MS
Radiation oncologist -
Harish N. Vasudevan
MD, PhD
Radiation oncologist -
Sue Yom
MD, PhD
Radiation oncologist
-
Lauren Boreta
MD
Radiation oncologist -
Steve Braunstein
MD, PhD
Radiation oncologist -
Jessica Chew
MD
Radiation oncologist -
Shannon Fogh
MD
Radiation oncologist -
Julie Frank
LCSW, MSW
Social worker -
Christine Glastonbury
MBBS
Neuroradiologist -
S. John Liu
MD, PhD
Radiation oncologist -
Jean L. Nakamura
MD
Radiation oncologist -
David R. Raleigh
MD, PhD
Radiation oncologist -
Penny K. Sneed
MD, FACR
Radiation oncologist -
Matt Susko
MD, MS
Radiation oncologist -
Harish N. Vasudevan
MD, PhD
Radiation oncologist -
Emily C. Yee
FNP, MSN
Nurse practitioner
Clinical trials
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
PFS is defined as the proportion of participants alive without progression of disease from the first day of radiotherapy to progression or death by any cause, whichever occurs first, assessed up to 2 years after the last day of ra...
Recruiting
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meni...
Percentage of patients who are progression-free at the landmark of 12 months from start of treatment based on the target lesion(s) that are receiving radiation treatment will be reported. Tumor progression will be assessed using I...
Recruiting
Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Can...
Defined per Response Evaluation Criteria in Solid Tumors 1.1, excluding radiation therapy-treated lesions. assessed from initiation of study treatment until discontinuation of treatment. Proportion of response and corresponding ex...
Recruiting
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Proportion of patients who achieve as their best overall response according to Response Evaluation Criteria in Solid Tumors (RECIST) v. 1.1 criteria: Stable disease (SD), partial response (PR), confirmed Complete Response (CR), or...
Recruiting
Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiatio...
The Taste Assessment is a two-item questionnaire used to determine the overall experiences of the participant taste sensation in the past 7 days; with one item asking about taste alteration and another asking about the interferenc...
Recruiting
U.S. News rankings
-
Among the top hospitals in the nation
-
Best in Northern California and No. 7 in the nation for cancer care
Accreditations & memberships
-
National Cancer Institute
The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
-
Commission on Cancer
UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
-
National Comprehensive Cancer Network
UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Support services
Plan your visit
What to Bring
- Medical records (must be received two weeks prior to appointment)
- List of current medications, dosages and prescribing doctors
- List of any other doctors involved in your care
Our research initiatives
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.